Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;2(6):477-86.
doi: 10.1007/s13238-011-1065-7. Epub 2011 Jul 12.

Expression of human FUS protein in Drosophila leads to progressive neurodegeneration

Yanbo Chen  1 , Mengxue Yang, Jianwen Deng, Xiaoping Chen, Ye Ye, Li Zhu, Jianghong Liu, Haihong Ye, Yan Shen, Yan Li, Elizabeth J Rao, Kazuo Fushimi, Xiaohong Zhou, Eileen H Bigio, Marsel Mesulam, Qi Xu, Jane Y Wu
Affiliations

Expression of human FUS protein in Drosophila leads to progressive neurodegeneration

Yanbo Chen et al. Protein Cell. 2011 Jun.

Abstract

Mutations in the Fused in sarcoma/Translated in liposarcoma gene (FUS/TLS, FUS) have been identified among patients with amyotrophic lateral sclerosis (ALS). FUS protein aggregation is a major pathological hallmark of FUS proteinopathy, a group of neurodegenerative diseases characterized by FUS-immunoreactive inclusion bodies. We prepared transgenic Drosophila expressing either the wild type (Wt) or ALS-mutant human FUS protein (hFUS) using the UAS-Gal4 system. When expressing Wt, R524S or P525L mutant FUS in photoreceptors, mushroom bodies (MBs) or motor neurons (MNs), transgenic flies show age-dependent progressive neural damages, including axonal loss in MB neurons, morphological changes and functional impairment in MNs. The transgenic flies expressing the hFUS gene recapitulate key features of FUS proteinopathy, representing the first stable animal model for this group of devastating diseases.

PubMed Disclaimer

References

    1. Aman P., Panagopoulos I., Lassen C., Fioretos T., Mencinger M., Toresson H., Höglund M., Forster A., Rabbitts T.H., Ron D., et al. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics. 1996;37:1–8. doi: 10.1006/geno.1996.0513. - DOI - PubMed
    1. Bachmann A., Kobler O., Kittel R.J., Wichmann C., Sierralta J., Sigrist S.J., Gundelfinger E.D., Knust E., Thomas U. A perisynaptic ménage à trois between Dlg, DLin-7, and Metro controls proper organization of Drosophila synaptic junctions. J Neurosci. 2010;30:5811–5824. doi: 10.1523/JNEUROSCI.0778-10.2010. - DOI - PMC - PubMed
    1. Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem. 1999;274:34337–34342. doi: 10.1074/jbc.274.48.34337. - DOI - PubMed
    1. Bäumer D., Hilton D., Paine S.M., Turner M.R., Lowe J., Talbot K., Ansorge O. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611–618. doi: 10.1212/WNL.0b013e3181ed9cde. - DOI - PMC - PubMed
    1. Belly A., Moreau-Gachelin F., Sadoul R., Goldberg Y. Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci Lett. 2005;379:152–157. doi: 10.1016/j.neulet.2004.12.071. - DOI - PubMed

Publication types

MeSH terms